论文部分内容阅读
目的观察洛伐他汀联合复方丹参滴丸治疗高血脂合并冠心病的临床疗效。方法将2011年3月-2012年9月我院冠心病合并高血脂患者80例随机分为两组各40例。在常规治疗的基础上,对照组给予洛伐他汀治疗,治疗组给予洛伐他汀联合复方丹参滴丸治疗,观察治疗后两组患者心绞痛、ECG情况,TC、LDL-C指标,比较两组疗效。结果治疗组患者心绞痛疗效有效率、ECG有效率高于对照组,差异有统计学意义(P<0.05);两组治疗后血脂水平均较治疗前显著降低,差异有统计学意义(P<0.05),组间血脂水平差异不大(P>0.05)。结论洛伐他汀联合复方丹参滴丸治疗高血脂合并冠心病疗效满意,值得临床推广。
Objective To observe the clinical efficacy of lovastatin and compound Danshen dripping pills in treating hyperlipidemia and coronary heart disease. Methods From March 2011 to September 2012, 80 patients with coronary heart disease complicated with hyperlipidemia were randomly divided into two groups of 40 cases. On the basis of routine treatment, the control group was treated with lovastatin, the treatment group was treated with lovastatin combined with compound Danshen dripping pills, angina pectoris, ECG, TC, LDL-C index were observed in both groups after treatment . Results The effective rate of angina pectoris and the effective rate of ECG in the treatment group were significantly higher than those in the control group (P <0.05). The blood lipid levels of the two groups after treatment were significantly lower than those before treatment (P <0.05 ), There was no significant difference between the two groups (P> 0.05). Conclusion Lovastatin combined with compound Danshen dripping pills in treating hyperlipidemia and coronary heart disease is effective and worthy of clinical promotion.